Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial

Autor: Kathryn P. Gray, Karen N. Price, Brandon Young, Rudolf Maibach, Beat Thürlimann, Birgitte Bruun Rasmussen, Maria Olivia Biasi, Henrik J. Ditzel, Aron Goldhirsch, Isabelle Treilleux, Patrizia Dell'Orto, Roswitha Kammler, Patrick Neven, James M. Rae, Brian Leyland-Jones, Vernon Harvey, Bradley C. Long, Giuseppe Viale, Mark Bouzyk, Maria Bibi Lyng, Alan S. Coates, Meredith M. Regan, Olivia Pagani, Mark Abramovitz

Publikováno v: Leyland-Jones, B, Gray, K P, Abramovitz, M, Bouzyk, M, Young, B, Long, B, Kammler, R, Dell'Orto, P, Biasi, M O, Thürlimann, B, Lyng, M B, Ditzel, H J, Harvey, V J, Neven, P, Treilleux, I, Rasmussen, B B, Maibach, R, Price, K N, Coates, A S, Goldhirsch, A, Pagani, O, Viale, G, Rae, J M & Regan, M M 2015, ' CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial ', Breast Cancer Research and Treatment, vol. 151, no. 2, pp. 373-384 . https://doi.org/10.1007/s10549-015-3378-3

To determine whether CYP19A1 polymorphisms are associated with abnormal activity of aromatase and with musculoskeletal and bone side effects of aromatase inhibitors. DNA was isolated from tumor specimens of 4861 postmenopausal women with hormone rece

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc26de57e5ab4b451a3117fb5d9344f
https://portal.findresearcher.sdu.dk/da/publications/28d44203-60bd-4247-b24c-57ae5f983f71